Related Experiment Video

Updated: Apr 4, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

IκB kinase α functions as a tumor suppressor in epithelial-derived tumors through an NF-κB-independent pathway

Yuxin Xie1, Keqi Xie2, Qiheng Gou3

  • 1Department of Radiation Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Oncology Reports
|September 2, 2015
PubMed

Insights

IκB kinase α (IKKα) acts as a tumor suppressor in epithelial cancers. Overexpression of IKKα may prevent tumor progression by regulating keratinocyte differentiation and proliferation via a novel pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • IκB kinase α (IKKα) is implicated in human skin cancer.
  • IKKα regulates keratinocyte terminal differentiation and proliferation.
  • IKKα deficiency or mutation correlates with tumor development.

Purpose of the Study:

  • To investigate the role of IKKα as a tumor suppressor in epithelial-derived tumors.
  • To elucidate the IKKα activation pathway distinct from the NF-κB pathway.
  • To provide a theoretical basis for understanding IKKα-related tumor mechanisms.

Main Methods:

  • Literature review and theoretical analysis of IKKα function.
  • Comparative analysis of IKKα's role in skin cancer and other epithelial tumors.
  • Exploration of IKKα's unique activation pathway.

Main Results:

  • IKKα functions as a tumor suppressor in epithelial-derived tumors.
  • IKKα's activation pathway differs from the canonical NF-κB pathway.
  • Overexpression of IKKα shows potential in preventing tumor progression.

Conclusions:

  • IKKα is a crucial tumor suppressor in epithelial cancers.
  • Understanding IKKα's distinct activation pathway is key to novel therapeutic strategies.
  • Further research into IKKα-mediated pathways can advance cancer treatment.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K